Increases in α4* but not α3*/α6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment

Journal of Neurochemistry

Volumn 96, Issue 4, 2006, Pages 1028-1041

  McCallum, Sarah E ^a   Parameswaran, Neeraja ^a   Bordia, Tanuja ^a   Fan, Hong ^b   Tyndale, Rachel F ^c   Langston, J William ^a   McIntosh, J Michael ^d   Quik, Maryka ^a  

^a PARKINSON S INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

3H dopamine release; Chronic nicotine treatment; Nicotinic acetylcholine receptors; Non human primate; Striatum; Up regulation

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; 3' HYDROXYCOTININE; ALPHA CONOTOXIN MII; COTININE; DOPAMINE; DRINKING WATER; DRUG METABOLITE; EPIBATIDINE; IODINE 125; LIGAND; NICOTINE; NICOTINIC RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN SYNAPTOSOME; CIGARETTE SMOKING; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LONG TERM EXPOSURE; NONHUMAN; PLASMA; PRIMATE; PRIORITY JOURNAL; TOBACCO DEPENDENCE; ANIMAL; BLOOD; CEBIDAE; DRUG EFFECT; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PUTAMEN; SYNAPTOSOME; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALIA; NICOTIANA TABACUM; PRIMATES;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL TRANSPORT; CORPUS STRIATUM; COTININE; DOPAMINE; NICOTINE; PUTAMEN; RECEPTORS, NICOTINIC; SAIMIRI; SYNAPTOSOMES;

EID: 33645099942     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03646.x     Document Type: Article

References (55)

1. 3H]nicotine binding sites in human brain JNeurochem 50 1243 1247
2. 3H]nicotine binding in human post-mortem brain JPharmacolExpTher 282 7 13
3. Brooks DJ. Ibanez V. Sawle GV. Quinn N. Lees AJ. Mathias CJ. Bannister R. Marsden CD. Frackowiak RS. 1990 Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy AnnNeurol 28 547 555
4. Buisson B. Bertrand D. 2001 Chronic exposure to nicotine up-regulates the human α4β2 nicotinic acetylcholine receptor function JNeurosci 21 1819 1829
5. Champtiaux N. Han ZY. Bessis A. Rossi FM. Zoli M. Marubio L. McIntosh JM. Changeux JP. 2002 Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice JNeurosci 22 1208 1217
6. Creese I. Sibley DR. 1981 Receptor adaptations to centrally acting drugs AnnuRevPharmacolToxicol 21 357 391
7. 125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina JNeurochem 85 1237 1246
8. Emmers R. Akert K. 1963 A Stereotaxic Atlas of the Brain of the Squirrel Monkey (Samiri Sciureus), pp. 24 27 q9 University of Wisconsin Press Madison, WI
9. Flores CM. Rogers SW. Pabreza LA. Wolfe BB. Kellar KJ. 1992 A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment MolPharmacol 41 31 37
10. Flores CM. Davila-Garcia MI. Ulrich YM. Kellar KJ. 1997 Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration JNeurochem 69 2216 2219
11. Giniatullin R. Nistri A. Yakel JL. 2005 Desensitization of nicotinic ACh receptors: shaping cholinergic signaling Trends Neurosci 28 371 378
12. Gopalakrishnan M. Molinari EJ. Sullivan JP. 1997 Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways MolPharmacol 52 524 534
13. 3H]dopamine release from mouse striatal synaptosomes and response to chronic 1-nicotine treatment JPharmacolExpTher 282 32 43
14. 3H]dopamine release from synaptosomes prepared from four mouse brain regions JPharmacolExpTher 301 651 660
15. Grilli M. Parodi M. Raiteri M. Marchi M. 2005 Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release JNeurochem 93 1353 1360
16. Hukkanen J. Jacob P. 3rd and Benowitz NL. 2005 Metabolism and disposition kinetics of nicotine PharmacolRev 57 79 115
17. 3H]dopamine release in rat striatum JNeurochem 56 603 610
18. Katz B. Thesleff S. 1957 A study of the desensitization produced by acetylcholine at the motor end-plate JPhysiol 138 63 80
19. Kish SJ. Shannak K. Hornykiewicz O. 1988 Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications NEnglJMed 318 876 880
20. Kulak JM. Nguyen TA. Olivera BM. McIntosh JM. 1997 α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes JNeurosci 17 5263 5270
21. Kulak JM. McIntosh JM. Quik M. 2002a Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in α-conotoxin MII sites MolPharmacol 61 230 238
22. Kulak JM. Musachio JL. McIntosh JM. Quik M. 2002b Declines in different β2* nicotinic receptor populations in monkey striatum after nigrostriatal damage JPharmacolExpTher 303 633 639
23. Lai A. Parameswaran N. Khwaja M. Whiteaker P. Lindstrom JM. Fan H. McIntosh JM. Grady SR. Quik M. 2005 Long-term nicotine treatment decreases striatal α6* nicotinic acetylcholine receptor sites and function in mice MolPharmacol 67 1639 1647
24. Marks MJ. Burch JB. Collins AC. 1983 Effects of chronic nicotine infusion on tolerance development and nicotinic receptors JPharmacolExpTher 226 817 825
25. Marks MJ. Grady SR. Collins AC. 1993 Down-regulation of nicotinic receptor function after chronic nicotine infusion JPharmacolExpTher 266 1268 1276
26. 125I]- epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment Neuropharmacology 46 1141 1157
27. McCallum SE. Collins AC. Paylor R. Marks MJ. 2005a Deletion of the β2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation Psychopharmacology (Berl) in pressq10
28. McCallum SE. Parameswaran N. Bordia T. McIntosh JM. Grady SR. Quik M. 2005b Decrease in α3*/α6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage MolPharmacol 68 737 746
29. Middleton LS. Cass WA. Dwoskin LP. 2004 Nicotinic receptor modulation of dopamine transporter function in rat striatum and medial prefrontal cortex JPharmacolExpTher 308 367 377
30. Moratalla R. Quinn B. DeLanney LE. Irwin I. Langston JW. Graybiel AM. 1992 Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine ProcNatl AcadSciUSA 89 3859 3863
31. Musachio JL. Villemagne VL. Scheffel UA. Dannals RF. Dogan AS. Yokoi F. Wong DF. 1999 Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon NuclMedBiol 26 201 207
32. Nguyen HN. Rasmussen BA. Perry DC. 2003 Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography JPharmacolExpTher 307 1090 1097
33. Parker SL. Fu Y. McAllen K. Luo J. McIntosh JM. Lindstrom JM. Sharp BM. 2004 Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the α6 subunit MolPharmacol 65 611 622
34. Peng X. Gerzanich V. Anand R. Whiting PJ. Lindstrom J. 1994 Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover MolPharmacol 46 523 530
35. Perry DC. Davila-Garcia MI. Stockmeier CA. Kellar KJ. 1999 Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies JPharmacolExpTher 289 1545 1552
36. Petersen DR. Norris KJ. Thompson JA. 1984 A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice Drug MetabDispos 12 725 731
37. Pietila K. Lahde T. Attila M. Ahtee L. Nordberg A. 1998 Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment Naunyn Schmiedebergs ArchPharmacol 357 176 182
38. 125I-α-conotoxin MII binding sites to nigrostriatal damage in monkey JNeurosci 21 5494 5500
39. Quik M. Parameswaran N. Bordia T. Bao S. Kim A. Tyndale RF. Langston JW. Di Monte DA. McCallum SE. 2005a Chronic oral nicotine treatment protects against striatal degeneration in monkey brain Program No. 1006.3, Abstract Viewer/Itinerary Planner. Society for Neuroscience Washington, DC. Available from: q12.
40. Quik M. Vailati S. Bordia T. Kulak JM. Fan H. McIntosh JM. Clementi F. Gotti C. 2005b q11 Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l -DOPA MolPharmacol 67 32 41
41. Risso F. Parodi M. Grilli M. Molfino F. Raiteri M. Marchi M. 2004 Chronic nicotine causes functional up-regulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release NeurochemInt 44 293 301
42. Rowell PP. Wonnacott S. 1990 Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes JNeurochem 55 2105 2110
43. Sallette J. Bohler S. Benoit P. Soudant M. Pons S. Le Novere N. Changeux JP. Corringer PJ. 2004 An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine JBiolChem 279 18 767 18 775
44. Salminen O. Grady SR. Collins AC. McIntosh JM. Marks MJ. 2004a Chronic Nicotine Infusion Down-Regulates α-Conotoxin MII Sensitive Nicotinic Acetylcholine Receptors in C57Bl/6 Mice Program No. 48.21, Abstract Viewer/Itinerary Planner. Society for Neuroscience Washington, DC. Available from: q12.
45. Salminen O. Murphy KL. McIntosh JM. Drago J. Marks MJ. Collins AC. Grady SR. 2004b Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice MolPharmacol 65 1526 1535
46. Schoedel KA. Sellers EM. Palmour R. Tyndale RF. 2003 Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration MolPharmacol 63 96 104
47. Schwartz RD. Kellar KJ. 1983 Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo Science 220 214 216
48. 3H] acetylcholine recognition sites in brain by nicotinic cholinergic drugs JNeurochem 45 427 433
49. Sparks JA. Pauly JR. 1999 Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice Psychopharmacology (Berl) 141 145 153
50. Teaktong T. Graham AJ. Johnson M. Court JA. Perry EK. 2004 Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study NeuropatholApplNeurobiol 30 243 254
51. Visanji NP. Mitchell SN. O'Neill MJ. Duty S. 2005 Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat Neuropharmacologyq13 in press
52. Whiteaker P. Sharples CG. Wonnacott S. 1998 Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition MolPharmacol 53 950 962
53. 125I-α-Conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain MolPharmacol 57 913 925
54. Wonnacott S. Drasdo A. Sanderson E. Rowell P. 1990 Presynaptic nicotinic receptors and the modulation of transmitter release Ciba FoundSymp 152 87 105
55. Yu ZJ. Wecker L. 1994 Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices JNeurochem 63 186 194